Want to see CL full AI Analyst Report?
CL Stock Chart & Stats
$90.75
$1.23(1.36%)
At close: 4:00 PM EDT
$90.75
$1.23(1.36%)
Day’s Range― - ―
52-Week Range$74.55 - $99.33
Previous Close$91.71
Volume3.77M
Average Volume (3M)4.65M
Market Cap
$73.06B
Enterprise Value$80.24K
Total Cash (Recent Filing)$1.37B
Total Debt (Recent Filing)$7.86B
Price to Earnings (P/E)35.9
Beta0.11
Next Earnings
Oct 23, 2026EPS Estimate
0.93Next Dividend Ex-DateN/A
Dividend Yield2.3%
Share Statistics
EPS (TTM)2.54
Shares Outstanding800,189,330
10 Day Avg. Volume4,061,491
30 Day Avg. Volume4,654,399
Financial Highlights & Ratios
PEG Ratio-1.19
Price to Book (P/B)1.18K
Price to Sales (P/S)3.14
P/FCF Ratio17.58
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$99.77Price Target Upside9.94% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering14
EPS Forecast (FY)3.86
Revenue Forecast (FY)$21.42B
Bulls Say, Bears Say
Bulls Say
Free Cash Flow GenerationConsistent, large free cash flow (TTM ~$3.86B) funds dividends, buybacks and debt service, enabling durable capital allocation. Strong operating cash flow (~$4.46B) supports investment in brands, innovation and working capital, and provides a buffer through cycles.
Emerging Markets Revenue StrengthBroad-based organic growth led by emerging markets (mid-single digits) and standout country performance (India double-digits) diversifies revenue sources. Geographic breadth reduces dependence on any single economy and supports more stable long-term top-line growth.
Hill's Premium Pet FranchiseHill's operates as a premium, higher-margin franchise with therapeutic and wet segments growing and e-commerce momentum. Its pricing power, clinical positioning and category mix offer durable structural tailwinds and a stable profit contributor over time.
Bears Say
High Financial LeverageVery high leverage and an unusually small equity base materially reduce financial flexibility. Elevated debt-to-equity (~33x) raises refinancing, covenant and interest-rate sensitivity risks, limiting the company's ability to invest or absorb earnings shocks over the medium term.
Margin Compression Vs. 2024Profitability has meaningfully cooled versus 2024, with TTM net margin declining to ~9.7% from ~14.4%. Sustained margin pressure reduces internal funding for growth and shareholder returns, and increases vulnerability to raw material and tariff cost swings.
Channel & Private-Label HeadwindsRetail destocking (shipments down ~3% vs consumption flat) and private-label gains in pet (≈200bps volume hit) create structural headwinds to volume and visibility. These channel dynamics can persist, pressuring organic growth and forcing continued promotional or trade spend.
Colgate-Palmolive News
CL FAQ
What was Colgate-palmolive Company’s price range in the past 12 months?
Colgate-palmolive Company lowest stock price was $74.55 and its highest was $99.33 in the past 12 months.
What is Colgate-palmolive Company’s market cap?
Colgate-palmolive Company’s market cap is $73.06B.
When is Colgate-palmolive Company’s upcoming earnings report date?
Colgate-palmolive Company’s upcoming earnings report date is Oct 23, 2026 which is in 74 days.
How were Colgate-palmolive Company’s earnings last quarter?
Colgate-palmolive Company released its earnings results on Jul 31, 2026. The company reported $0.99 earnings per share for the quarter, beating the consensus estimate of $0.947 by $0.043.
Is Colgate-palmolive Company overvalued?
According to Wall Street analysts Colgate-palmolive Company’s price is currently Undervalued.
Does Colgate-palmolive Company pay dividends?
Colgate-palmolive Company pays a Quarterly dividend of $0.53 which represents an annual dividend yield of 2.3%. See more information on Colgate-palmolive Company dividends here
What is Colgate-palmolive Company’s EPS estimate?
Colgate-palmolive Company’s EPS estimate is 0.93.
How many shares outstanding does Colgate-palmolive Company have?
Colgate-palmolive Company has 800,189,330 shares outstanding.
What happened to Colgate-palmolive Company’s price movement after its last earnings report?
Colgate-palmolive Company reported an EPS of $0.99 in its last earnings report, beating expectations of $0.947. Following the earnings report the stock price went down -0.328%.
Which hedge fund is a major shareholder of Colgate-palmolive Company?
Currently, no hedge funds are holding shares in CL
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Colgate-Palmolive Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$99.77 (9.94% Upside)
$99.77 (9.94% Upside)
Blogger Sentiment
Bullish
CL Sentiment 71%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 3.1M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $1.3M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Negative
Last 7 Days ▼ 1.6%
Last 30 Days ▼ 0.3%
Last 30 Days ▼ 0.3%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
7.22%
12-Months-Change
Fundamentals
Return on Equity
2.30%
Trailing 12-Months
Asset Growth
-3.89%
Trailing 12-Months
Company Description
Colgate-palmolive Company
Operating globally, Colgate-Palmolive Company and its affiliated entities are engaged in the production and distribution of a diverse range of consumer goods. Its operations are structured into two primary divisions: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care division encompasses a broad array of offerings, spanning oral hygiene (e.g., toothpastes, toothbrushes, mouthwashes), personal care (e.g., bar and liquid soaps, shower gels, shampoos, conditioners, deodorants, antiperspirants, skin health items), and home care solutions (e.g., dishwashing detergents, fabric conditioners, household cleaners). These products are distributed through various channels, including traditional and online retailers, wholesalers, and distributors, under well-known brand names such as Colgate, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, Irish Spring, Palmolive, Protex, Sanex, Softsoap, Lady Speed Stick, Speed Stick, EltaMD, Filorga, PCA SKIN, Ajax, Axion, Fabuloso, Murphy, Suavitel, Soupline, and Cuddly. Furthermore, this segment supplies specialized pharmaceutical products to dentists and other professionals in oral healthcare. Conversely, the Pet Nutrition segment focuses on providing specialized pet food. This includes everyday nutritional options marketed under the Hill's Science Diet brand, as well as therapeutic diets designed to assist in managing various health conditions in dogs and cats, sold under the Hill's Prescription Diet brand. Distribution for these pet nutrition items occurs via pet supply stores, veterinary clinics, and online retail platforms. Established in 1806, Colgate-Palmolive Company maintains its corporate headquarters in New York, New York.
CL Company Deck
CL Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call communicated a predominantly constructive operating performance — broad-based organic growth across divisions, meaningful gross margin expansion, improved guidance, strong free cash flow (+18%) and sizable shareholder returns ($1.4B). Hill's and emerging markets were notable growth drivers, and management is increasing investment in advertising, innovation and AI. Offsetting these positives are persistent macro and category headwinds: U.S. softness and volatility, retailer inventory destocking (shipments down ~3%), private-label pressure in pet (-200 bps impact), and the risk of higher raw material and tariff costs in H2. Management emphasized prudent guidance and specific remedial actions for the U.S. business while citing confidence in the global operating model.View all CL earnings summariesCL Net sales Breakdown
77.37% Oral, Personal and Home Care
22.63% Pet Nutrition

CL Stock 12 Month Forecast
All Analysts
Top Analysts
Average Price Target
$99.77
▲(9.94% Upside)
Technical Analysis
1 Day
3 Days
1 Week
1 Month
Ownership Overview
0.15% Insiders
20.72% Mutual Funds
7.44% Other Institutional Investors
47.56% Public Companies and Individual Investors










